Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

by Business Wire • 2021/04/29 • 0 Comments

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. With the ARVO 2021 Annual Meeting being moved to a virtual format, video-recorded presentations are scheduled to become available online at ARVO

← NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6

First Segment of Kopin’s Three Part Webinar Series "AR and VR: The Paradigm Shift to Smartglasses Starts Now" Draws Over 300 Participants →

Post navigation